MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease

In patients with inflammatory bowel disease (IBD), a treat-to-target treatment strategy requires tight monitoring of disease activity. Noninvasive biomarkers may help to monitor the intestinal disease activity. We demonstrated recently that peripheral microRNA (miR)-320a expression in mice follows t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordes, Friederike, Demmig, Claudia, Bokemeyer, Arne, Brückner, Markus, Lenze, Frank, Lenz, Philipp, Nowacki, Tobias, Tepasse, Phil, Schmidt, Hartmut H., Schmidt, M. Alexander, Cichon, Christoph, Bettenworth, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145033/
https://www.ncbi.nlm.nih.gov/pubmed/32352717
http://dx.doi.org/10.14309/ctg.0000000000000134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145033/
https://www.ncbi.nlm.nih.gov/pubmed/32352717
http://dx.doi.org/10.14309/ctg.0000000000000134

Ejemplares similares